Published in J Lab Clin Med on November 01, 1985
Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthop Res (2008) 1.20
The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med (2008) 1.13
The longitudinal assessment of osteomyelitis development by molecular imaging in a rabbit model. Biomed Res Int (2014) 0.87
Chemical synovectomy with sodium morrhuate in the treatment of symptomatic recurrent knee joint effusion. Rheumatol Int (2011) 0.79
A novel canine model of acute pyogenic spondylodiscitis. Neurosurg Rev (2009) 0.76
Drug-induced pulmonary vascular disease--mechanisms and clinical patterns. West J Med (1986) 0.76
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest (1978) 5.80
Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest (1977) 5.16
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest (1977) 4.08
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest (1992) 3.50
Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med (1977) 3.43
Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int (2001) 3.07
Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A (1993) 2.77
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis (1995) 2.65
Endoscopic complications. Results of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA (1976) 2.55
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism. J Lab Clin Med (1984) 2.52
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood (1993) 2.48
Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet (1980) 2.47
Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med (1980) 2.41
Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest (1980) 2.34
Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation. Gastroenterology (1972) 2.31
Purification and properties of gentisate 1,2-dioxygenase from Moraxella osloensis. J Bacteriol (1975) 2.15
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood (2000) 2.10
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria. Am J Pathol (1985) 2.08
Leukocytes and the risk of ischemic diseases. JAMA (1987) 2.03
Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states. J Clin Invest (1979) 2.01
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99
Elevated erythrocyte calcium in sickle cell disease. Nature (1973) 1.97
In vitro granulocyte adherence and in vivo margination: two associated complement-dependent functions. Studies based on the acute neutropenia of filtration leukophoresis. J Exp Med (1977) 1.94
Plasma exchange in the treatment of immune disease. Transfusion (1976) 1.81
Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation. N Engl J Med (1974) 1.80
Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation. Blood (1980) 1.77
Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest (1991) 1.77
Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75
Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor. J Pediatr (1994) 1.70
Molecular mimicry in Candida albicans. Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest (1991) 1.68
Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies. Ann Intern Med (1993) 1.67
Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation (1999) 1.66
Reperfusion injury pathophysiology in sickle transgenic mice. Blood (2000) 1.65
Effects of sulfhydryl inhibition on red blood cells. 3. Glutathione in the regulation of the hexose monophosphate pathway. J Biol Chem (1966) 1.62
Sudden blindness in acute pancreatitis. Possible role of complement-induced retinal leukoembolization. Arch Intern Med (1981) 1.62
Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med (1971) 1.60
Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest (1979) 1.54
Fluoroscopy is not necessary for Maloney dilation of chronic esophageal strictures. Gastrointest Endosc (1995) 1.53
Complement activation and pulmonary leukotasis during nylon fiber filtration leukapheresis. Blood (1978) 1.52
Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb (1991) 1.49
Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science (1973) 1.49
Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med (1990) 1.48
Secretion of pancreatic enzymes. I. Response to secretin and pancreozymin. Am J Dig Dis (1966) 1.46
Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions. Kidney Int (2006) 1.46
The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort. Transfusion (2010) 1.45
Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest (1993) 1.45
Abnormal haem binding and globin SH group blockade in unstable haemoglobins. Nature (1968) 1.44
Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood (2001) 1.44
Abnormal zinc metabolism in type II diabetes mellitus. Am J Med (1983) 1.42
Deleterious effects of endotoxin on cultured endothelial cells: an in vitro model of vascular injury. Inflammation (1981) 1.40
Concentration of citrate anticoagulant in peripheral blood progenitor cell collections. Transfusion (1996) 1.39
Complement-mediated granulocyte dysfunction in paroxysmal nocturnal hemoglobinuria. Blood (1976) 1.37
A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol (1985) 1.35
Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Lab Invest (1995) 1.34
Granulocyte aggregation as a manifestation of membrane interactions with complement: possible role in leukocyte margination, microvascular occlusion, and endothelial damage. Semin Hematol (1979) 1.33
Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B. J Lab Clin Med (1978) 1.33
Effect of intravascular complement activation on granulocyte adhesiveness and distribution. Blood (1978) 1.31
Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol (1995) 1.31
Résumé of a seminar on endoscopic retrograde sphincterotomy (ERS). Gastrointest Endosc (1981) 1.31
A possible role for cyclic nucleotides in the regulation of erythrocyte shape and permeability. J Lab Clin Med (1976) 1.28
Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood (1988) 1.27
Membrane abnormalities of irreversibly sickled cells. Semin Hematol (1979) 1.27
Altered sulfhydryl reactivity of hemoglobins and red blood cell membranes in congenital Heinz body hemolytic anemia. J Clin Invest (1968) 1.26
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med (1990) 1.23
The role of hemoglobin heme loss in Heinz body formation: studies with a partially heme-deficient hemoglobin and with genetically unstable hemoglobins. J Clin Invest (1970) 1.22
Complications associated with esophagogastroduodenoscopy and with esophageal dilation. Gastrointest Endosc (1976) 1.22
Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol (1995) 1.22
Effect of cimetidine on the absorption of vitamin B12. Scand J Gastroenterol (1982) 1.21
Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1981) 1.21
Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol (2005) 1.20
Role of endothelial cells in human hematopoiesis: modulation of mixed colony growth in vitro. Blood (1984) 1.18
Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer. J Clin Gastroenterol (1985) 1.18
Chemotaxigenesis by cell surface components of Staphylococcus aureus. Infect Immun (1979) 1.17
Post-endoscopy pancreatitis and hyperamylasuria. Gastrointest Endosc (1973) 1.16